Total raised
$2.1M
Last: SAFE 2025-01
Stage
Seed
Founded
2017
Headcount
7
HQ
פארק תעשיות בר-לב
Sector
Health Tech & Life Sciences
About
Foresee Genomics is developing a DNA testing system for cancer patients that combines molecular biology and computational analysis. The companys tests are designed to provide physicians with the genetic data needed for determining treatment options. Foresee Genomics procedure requires low-cost equipment and is intended to be performed at the point of care, in hospitals or local clinics.
The nanopore sequencing platform is significantly inexpensive in comparison to all other NGS platform. The combined system of Foresee Genomic and the nanopore sequencer is an end-to-end solution for genomic diagnostics which is accurate and affordable.
Funding history · 3 rounds · $2.1M total
2025-01
SAFE
$1.3M
2024-02
Undisclosed
Undisclosed
2018-12
Seed
$800K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareBiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
healthcare-providersclinicspersonalizationdiagnosticshospitalsoncologydecision-makingcancerdigital-healthcarebiotechnologysaashematologyhardwaregenetic-disorders